asa statement glp-1 The 2023 position on receptor agonists has been overturned by three 2025 consensus statements. Continue the drug. Change the fast. ANZCA/ADS/GESA/NACOS, the Association of Anaesthetists/RCoA, and SPAQI/AACE now converge on Future of Stroke Prevention: 7

Learn about blurry vision and vision loss from Ozempic, potential risks like NAION, study findings, prevention tips, and legal options for affected users.

Doctor-led weight care across India.

GLP-1 therapy is a proven tool for weight management and metabolic health, but side effects can interfere with consistency

New research suggests that stopping GLP-1 drugs may raise risks of heart attack and stroke, complicating the booming weight loss trend.

Codeage GLP-1 Probiotic+ is carefully formulated to meet the needs of individuals with dietary restrictions

Unlock free access to the WeightWatchers GLP-1 App, exclusively for CheqUp members